A Phase 2, Multi-centre, Open-label Study of Avelumab (MSB0010718C) in Locally Advanced or Metastatic Penile Cancer Patients Unfit for Platinum-based Chemotherapy or Progressed On or After Platinum-based Chemotherapy
Phase of Trial: Phase II
Latest Information Update: 27 Sep 2018
At a glance
- Drugs Avelumab (Primary)
- Indications Penile cancer; Squamous cell cancer
- Focus Therapeutic Use
- 18 Sep 2018 Status changed from not yet recruiting to recruiting.
- 10 Aug 2018 Planned initiation date changed from 1 Feb 2018 to 1 Sep 2018.
- 08 Jan 2018 New trial record